3.50
price up icon9.37%   0.30
after-market Handel nachbörslich: 3.44 -0.06 -1.71%
loading

Finanzdaten der Xbiotech Inc-Aktie (XBIT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.55
- 7.904 14.97 10.85
Operating Income/Loss
54.89%
-13.55
-8.748 -7.904 -14.97 -10.85
Nonoperating Income/Loss
249.64%
2.695
-1.801 2.898 1.935 0.876
Income/Loss From Continuing Operations Before Tax
2.90%
-10.86
-10.55 -5.006 -13.03 -9.977
Income Tax Expense/Benefit
170.73%
0.029
-0.041 0.009 -0.025 0.025
Income/Loss From Continuing Operations After Tax
3.58%
-10.88
-10.51 -5.015 -13.01 -10.00
Net Income/Loss
3.58%
-10.88
-10.51 -5.015 -13.01 -10.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.69M%
30.49
0.0018 30.47 30.46 30.44
Basic Earnings Per Share
5.88%
-0.36
-0.34 -0.16 -0.43 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):